Back

The role of soluble st2 and galectin-3 in hypertrophic cardiomyopathy assessed by cardiac magnetic resonance

2 May 2017 (08:00 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Hypertrophic cardiomyopathy Hypertrophic cardiomyopathy HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Monika Gawor

Institute of Cardiology, Warsaw (Poland)

5 More presentations in this session

Presentation thumbnail
Mr C. Klein (Lille, FR)
Presentation thumbnail
Doctor L. Marques (Sra. da Hora, PT)
Abstract
Presentation thumbnail
Doctor L. Marques (Sra. da Hora, PT)
Abstract
Presentation thumbnail
Mrs A. Demkina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Miss A. Polyakova (Saint Petersburg, RU)

Access the full session

Session thumbnail
Poster Session 4 - Hypertrophic cardiomyopathy

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

2 May 2017 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Head-to-head comparison of NT-proBNP and soluble ST2 for long-term prognosis of patients with hypertrophic cardiomyopathy
27 August 2021
thumbnail
Congress Session
Taking a deeper dive in cardiomyopathies
19 May 2025
thumbnail
Congress Presentation
Galectin 3 : possible tool for early detection of LV diastolic dysfunction in asymptomatic survivors of childhood, adolescent and young adult cancer
20 June 2025
thumbnail
Congress Presentation
Microvascular dysfunction and myocardial fibrosis impact on left ventricular myocardial deformation in hypertrophic cardiomyopathy: per segment analysis by magnetic resonance imaging
9 December 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources